Lower Alzheimer’s risk seen with PDE5i initiation for erectile dysfunction
Feb 08, 2024
The greatest reduction in risk was seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions.
Transcranial direct current stimulation beneficial in Alzheimer’s disease
Dec 07, 2023
Active tCDS improves cognitive functions in memory domain, including word recall, recall of test instructions and word recognition.
FDA delays decision on new Alzheimer’s drug
Mar 08, 2024
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely...
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Vasomotor symptoms linked to increased risk for Alzheimer’s disease
Sep 27, 2023
Objectively assessed VMS (so-called hot flashes), including sleep VMS, are associated with significantly lower amyloid-β42/40.
New framework for national plan on aging aims to ease access to LTSS for older adults
By
Kimberly Bonvissuto
May 31, 2024
Creating a more person-centered, accessible system of care to enable older adults to more easily connect with long-term services and supports is part of a strategic framework for a national plan on aging...
Illinois first state to legislatively mandate Alzheimer’s coverage by state health plans
By
Kimberly Bonvissuto
May 31, 2024
Illinois has become the first state to legislatively enact a requirement for state employee health insurance to provide Alzheimer’s treatment coverage.
New hobbies can help residents preserve, enhance cognitive function
By
Dori Ray
Nov 20, 2023
Supporting senior living residents with interesting programming supports their experience and growth, which ultimately preserves and enhances their cognitive functions.
Ultrasound tech could allow for ultrafast Alzheimer’s treatment, study finds
By
Aaron Dorman
Jan 09, 2024
Researchers have found a way to deliver Alzheimer’s drugs faster via focused ultrasound technology, a new study shows.